- Email: [email protected]
Air pollution as a cause of heart disease
Journal of the American College of Cardiology © 2002 by the American College of Cardiology Foundation Published by Elsevier Science Inc.
EDITORIAL COMMENT
Air Pollution as a Cause of Heart Disease Time for Action* Stanton A. Glantz, PHD, FACC San Francisco, California The environmental controls that have been developed over the last quarter century have, for the most part, been designed to reduce respiratory disease and cancer. In contrast, public health measures designed to reduce heart disease have concentrated on individual risk factors (1). Over the last decade, however, there has been growing epidemiological evidence that elevated levels of air pollution, particularly increased levels of fine particulates (smaller than 10 m in diameter, PM10 or 2.5 m, PM2.5), are associated with increased hospitalization (2) and mortality from cardiovascular disease (3–5). See page 935 The study by Suwa et al. (6) in this issue of the Journal provides important experimental evidence to support the conclusion that these epidemiological results are reflecting real effects of particulate pollution directly on the cardiovascular system. The investigators present convincing experimental evidence that particulate air pollution induces progression of atherosclerosis. They exposed rabbits to small particles (most ⬍3 m) collected from outdoor air in Ottawa, Canada by intrapharyngeal installation twice a week for four weeks, then measured responses in the lung, bone marrow, coronary arteries and aorta. The delivered dose at the level of the alveolar surface, estimated to be 23.2 ng/cm2, was less than the estimated human exposure of 35.1 ng/cm2 based on average pollution levels in six U.S. cities (3). Compared to a control group, the rabbits exposed to the particles from the air pollution experienced a systemic inflammatory response that included bone marrow stimulation and progression of atherosclerotic lesions in the coronary arteries and aorta. The extent of the atherosclerotic effects correlated with the extent of particulates phagocytosed by alveolar macrophages in the lung. The rabbits exposed to particulates had more advanced phenotypes of coronary lesions and increased plaque size. There was histological evidence of more extensive atherosclerosis in the aorta, an increase in the volume fraction of the lesions made up of lipids, and increased cell turnover. Plaques with these *Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. From the University of California, San Francisco, California. Preparation of this editorial was supported by the Richard and Rhoda Goldman Fund.
Vol. 39, No. 6, 2002 ISSN 0735-1097/02/$22.00 PII S0735-1097(02)01709-6
characteristics are more likely to rupture and trigger a coronary event than collagenous plaques (7,8). The results reported by Suwa et al. (6) are consistent with human studies that found elevated levels of C-reactive protein, a marker of systemic inflammation, in people during times of increased particulate air pollution (9,10). During increased levels of particulate air pollution, individuals experience elevated levels of plasma viscosity (11) and other changes in blood chemistry, suggesting that the adhesive properties of red blood cells are increased (10). These changes would predict an increased risk of a coronary event during periods of heightened air pollution. Further support that these changes are due to the effects of air pollution comes from studies of the effects of secondhand tobacco smoke, which is, after all, indoor air pollution. Even short-term exposure to secondhand smoke increases platelet activation (12,13). Secondhand smoke also promotes atherosclerosis (14 –16). This effect does not depend on the nicotine in the smoke (17), further implicating general products of combustion of organic matter, similar to those products observed in outdoor air pollution. The fact that exposure to the secondhand smoke of just one cigarette a day accelerated the atherosclerotic process (15) also suggests that low doses of air pollutants can have important effects on the coronary circulation. Other organic pollutants, 7,12-dimethylbenz(a)anthracene (18) and 1,3-butadiene (19), are atherogenic in experimental animals exposed via inhalation. Although the precise mechanisms by which exposure to particulates affects the autonomic nervous system are unclear, there is strong and consistent evidence that increases in the level of particulate air pollution are associated with reduced heart rate variability (20,21) and increases in heart rate (22) and blood pressure (23,24). Decreased heart rate variability predicts a higher risk of cardiac death or arrhythmic events after acute myocardial infarction (MI), presumably reflecting the adverse effects of increased sympathetic tone (25,26). In addition to epidemiological evidence that increased air pollution produces these effects, similar changes were observed in a quasi-experimental study of boilermakers, which found that significant reductions in heart rate variability were associated with just a few hours of occupational exposure to increased particulate levels (27). Likewise, an experimental study of the effects of secondhand smoke on heart rate variability showed an average 12% reduction in heart rate variability after just 2 h of exposure in an airport smoking lounge (28). A study of 100 patients with implanted cardioverter-defibrillators (ICDs) observed a higher rate of discharges within two days of periods of elevated air pollution (NO, CO, fine carbon, and fine particulates), indicating an increased incidence of potentially life-threatening arrythmias (29). Secondhand smoke exposures produce rapid (in 30 min in human studies) deterioration in endothelial function in experimental animals (30) and humans (31–33). Second-
944
Glantz Editorial Comment
hand smoke also increases infarct size in experimental animals (16), an effect that can be partially blocked by administering L-arginine, which helps restore endothelial function (34). To date, there have not been studies of the effects of air pollution on endothelial function, but it is likely that some of the effects observed in the epidemiological studies are due to the influence of air pollution on endothelial function. This is a question worthy of future research. Finally, increases in air pollution are associated with increased risk of MI (29,35). A study in Boston reported that these effects occur quickly; the odds of an MI were significantly increased (odds ratio [OR] ⫽ 1.48, 95% confidence interval [CI], 1.09 –2.02) with an incr]ease in airborne particulate concentrations of 25 g/m3 during the 2-h period before the onset of the MI and an OR of 1.69 (95% CI, 1.13–2.34) for an increase of 20 g/m3 in the 24 h before event onset (29). All these effects indicate that air pollution has an impact on heart disease. Some of these effects may occur over time, as with acceleration of the progression of atherosclerosis, or very quickly, as with an increase in the risk of an arrhythmia or MI by acute inflammatory responses, altering platelet function, or, perhaps, endothelial function. These effects may be independent of, or synergistic with, alterations in autonomic tone as reflected in increases in heart rate and reductions in heart rate variability. In any event, it is clear that these risks are real and substantial. Indeed, of the estimated 53,000 deaths due to secondhand smoke, 37,000 are attributed to cardiovascular disease compared with only 3,000 attributed to lung cancer (12). (Other estimates put the cardiovascular death estimate as high as 62,000 [36].) If outdoor air pollution exhibits a similar pattern of risks, the toll due to heart disease could be much larger—and more immediate—than the burden of cancer and lung disease that has been used to develop current air pollution standards. It is time for organizations concerned with heart health, including the American College of Cardiology and the American Heart Association, as well as traditional environmental organizations and environmental regulators, to consider seriously the cardiovascular effects of air pollution when developing and implementing standards to clear the air and protect public health. Reprint requests and correspondence: Dr. Stanton A. Glantz, Professor of Medicine, Box 0130, University of California, San Francisco, California 94143. E-mail: [email protected].
REFERENCES 1. Glantz SA. Heart disease and the environment. J Am Coll Cardiol 1993;21:1473–4. 2. Poloniecki JD, Atkinson RW, de Leon AP, Anderson HR. Daily time series for cardiovascular hospital admissions and previous day’s air pollution in London, UK. Occup Environ Med 1997;54:535–40. 3. Dockery DW, Pope CA, 3rd, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329: 1753–9.
JACC Vol. 39, No. 6, 2002 March 20, 2002:943–5 4. Pope CA, 3rd, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995;151 3:669 –74. 5. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987–1994. N Engl J Med 2000;343:1742–9. 6. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002;39:935– 42. 7. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–71. 8. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844 –50. 9. Peters A, Frohlich M, Doring A, et al. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J 2001;22:1198 –204. 10. Seaton A, Soutar A, Crawford V, et al. Particulate air pollution and the blood. Thorax 1999;54:1027–32. 11. Peters A, Doring A, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997;349:1582–7. 12. Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation 1991;83:1–12. 13. Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA 1995;273:1047–53. 14. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation 1993;88: 1820 –5. 15. Penn A, Chen LC, Snyder CA. Inhalation of steady-state sidestream smoke from one cigarette promotes atherosclerotic plaque development. Circulation 1994:1363–7. 16. Zhu B-Q, Sun Y-P, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 1994;889:1282–90. 17. Sun YP, Zhu BQ, Browne AE, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation 2001;104:810 –4. 18. Penn A, Batastini G, Soloman J, Burns F, Albert R. Dose-dependent size increases of aortic lesions following chronic exposure to 7,12dimethylbenz(a)anthracene. Cancer Res 1981;41:588 –92. 19. Penn A, Snyder C. 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates atherosclerotic plaque development. Circulation 1996;93:552–7. 20. Pope CA, 3rd, Verrier RL, Lovett EG, et al. Heart rate variability associated with particulate air pollution. Am Heart J 1999;138:890 –9. 21. Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart rate variability. Circulation 2000;101:1267–73. 22. Peters A, Perz S, Doring A, Stieber J, Koenig W, Wichmann HE. Increases in heart rate during an air pollution episode. Am J Epidemiol 1999;150:1094 –8. 23. Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health 2001;91:571–7. 24. Linn WS, Gong H, Jr. Air pollution, weather stress, and blood pressure. Am J Public Health 2001;91:1345–6. 25. Singh N, Mironov D, Armstrong PW, Ross AM, Langer A, GUSTO ECG Substudy/nvestigators. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. Global Utilization of Streptokinase and TPA for Occluded Arteries. Circulation 1996;93:1388 –95. 26. Kleiger RE, Miller JP, Bigger JT, Jr., Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256 –62. 27. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 2001; 104:986 –91. 28. Pope CA, 3rd, Eatough DJ, Gold DR, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect 2001;109:711–6. 29. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001;103:2810 –5.
JACC Vol. 39, No. 6, 2002 March 20, 2002:943–5 30. Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995;130:1270 –5. 31. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 2001;286:436 –41. 32. Celermajer D, Adams M, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med 1996;334:150 –4. 33. Glantz SA, Parmley WW. Even a little secondhand smoke is dangerous. JAMA 2001;286:462–3. 34. Sun Y, Zhu B, Sievers R, Glantz S, Deedwania P, Parmley W.
Glantz Editorial Comment
945
L-Arginine preserves endothelial-dependent relaxation during environmental tobacco smoke in lipid-fed rabbits (abstr). Circulation 1994;90 Suppl I:I459. 35. Eilstein D, Quenel P, Hedelin G, Kleinpeter J, Arveiler D, Schaffer P. [Air pollution and myocardial infarction. Strasbourg France, 1984 – 89]. Rev Epidemiol Sante Publique 2001;49:13–25. 36. National Cancer Institute. Health effects of exposure to environmental tobacco smoke: the report of the California Environmental Protectional Agency (Smoking and Health Monograph 10). Bethesda, MD: National Cancer Institute; 1999. Report No.: NIH Pub. No. 88 – 4645.
EDITORIAL COMMENT
Air Pollution as a Cause of Heart Disease Time for Action* Stanton A. Glantz, PHD, FACC San Francisco, California The environmental controls that have been developed over the last quarter century have, for the most part, been designed to reduce respiratory disease and cancer. In contrast, public health measures designed to reduce heart disease have concentrated on individual risk factors (1). Over the last decade, however, there has been growing epidemiological evidence that elevated levels of air pollution, particularly increased levels of fine particulates (smaller than 10 m in diameter, PM10 or 2.5 m, PM2.5), are associated with increased hospitalization (2) and mortality from cardiovascular disease (3–5). See page 935 The study by Suwa et al. (6) in this issue of the Journal provides important experimental evidence to support the conclusion that these epidemiological results are reflecting real effects of particulate pollution directly on the cardiovascular system. The investigators present convincing experimental evidence that particulate air pollution induces progression of atherosclerosis. They exposed rabbits to small particles (most ⬍3 m) collected from outdoor air in Ottawa, Canada by intrapharyngeal installation twice a week for four weeks, then measured responses in the lung, bone marrow, coronary arteries and aorta. The delivered dose at the level of the alveolar surface, estimated to be 23.2 ng/cm2, was less than the estimated human exposure of 35.1 ng/cm2 based on average pollution levels in six U.S. cities (3). Compared to a control group, the rabbits exposed to the particles from the air pollution experienced a systemic inflammatory response that included bone marrow stimulation and progression of atherosclerotic lesions in the coronary arteries and aorta. The extent of the atherosclerotic effects correlated with the extent of particulates phagocytosed by alveolar macrophages in the lung. The rabbits exposed to particulates had more advanced phenotypes of coronary lesions and increased plaque size. There was histological evidence of more extensive atherosclerosis in the aorta, an increase in the volume fraction of the lesions made up of lipids, and increased cell turnover. Plaques with these *Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. From the University of California, San Francisco, California. Preparation of this editorial was supported by the Richard and Rhoda Goldman Fund.
Vol. 39, No. 6, 2002 ISSN 0735-1097/02/$22.00 PII S0735-1097(02)01709-6
characteristics are more likely to rupture and trigger a coronary event than collagenous plaques (7,8). The results reported by Suwa et al. (6) are consistent with human studies that found elevated levels of C-reactive protein, a marker of systemic inflammation, in people during times of increased particulate air pollution (9,10). During increased levels of particulate air pollution, individuals experience elevated levels of plasma viscosity (11) and other changes in blood chemistry, suggesting that the adhesive properties of red blood cells are increased (10). These changes would predict an increased risk of a coronary event during periods of heightened air pollution. Further support that these changes are due to the effects of air pollution comes from studies of the effects of secondhand tobacco smoke, which is, after all, indoor air pollution. Even short-term exposure to secondhand smoke increases platelet activation (12,13). Secondhand smoke also promotes atherosclerosis (14 –16). This effect does not depend on the nicotine in the smoke (17), further implicating general products of combustion of organic matter, similar to those products observed in outdoor air pollution. The fact that exposure to the secondhand smoke of just one cigarette a day accelerated the atherosclerotic process (15) also suggests that low doses of air pollutants can have important effects on the coronary circulation. Other organic pollutants, 7,12-dimethylbenz(a)anthracene (18) and 1,3-butadiene (19), are atherogenic in experimental animals exposed via inhalation. Although the precise mechanisms by which exposure to particulates affects the autonomic nervous system are unclear, there is strong and consistent evidence that increases in the level of particulate air pollution are associated with reduced heart rate variability (20,21) and increases in heart rate (22) and blood pressure (23,24). Decreased heart rate variability predicts a higher risk of cardiac death or arrhythmic events after acute myocardial infarction (MI), presumably reflecting the adverse effects of increased sympathetic tone (25,26). In addition to epidemiological evidence that increased air pollution produces these effects, similar changes were observed in a quasi-experimental study of boilermakers, which found that significant reductions in heart rate variability were associated with just a few hours of occupational exposure to increased particulate levels (27). Likewise, an experimental study of the effects of secondhand smoke on heart rate variability showed an average 12% reduction in heart rate variability after just 2 h of exposure in an airport smoking lounge (28). A study of 100 patients with implanted cardioverter-defibrillators (ICDs) observed a higher rate of discharges within two days of periods of elevated air pollution (NO, CO, fine carbon, and fine particulates), indicating an increased incidence of potentially life-threatening arrythmias (29). Secondhand smoke exposures produce rapid (in 30 min in human studies) deterioration in endothelial function in experimental animals (30) and humans (31–33). Second-
944
Glantz Editorial Comment
hand smoke also increases infarct size in experimental animals (16), an effect that can be partially blocked by administering L-arginine, which helps restore endothelial function (34). To date, there have not been studies of the effects of air pollution on endothelial function, but it is likely that some of the effects observed in the epidemiological studies are due to the influence of air pollution on endothelial function. This is a question worthy of future research. Finally, increases in air pollution are associated with increased risk of MI (29,35). A study in Boston reported that these effects occur quickly; the odds of an MI were significantly increased (odds ratio [OR] ⫽ 1.48, 95% confidence interval [CI], 1.09 –2.02) with an incr]ease in airborne particulate concentrations of 25 g/m3 during the 2-h period before the onset of the MI and an OR of 1.69 (95% CI, 1.13–2.34) for an increase of 20 g/m3 in the 24 h before event onset (29). All these effects indicate that air pollution has an impact on heart disease. Some of these effects may occur over time, as with acceleration of the progression of atherosclerosis, or very quickly, as with an increase in the risk of an arrhythmia or MI by acute inflammatory responses, altering platelet function, or, perhaps, endothelial function. These effects may be independent of, or synergistic with, alterations in autonomic tone as reflected in increases in heart rate and reductions in heart rate variability. In any event, it is clear that these risks are real and substantial. Indeed, of the estimated 53,000 deaths due to secondhand smoke, 37,000 are attributed to cardiovascular disease compared with only 3,000 attributed to lung cancer (12). (Other estimates put the cardiovascular death estimate as high as 62,000 [36].) If outdoor air pollution exhibits a similar pattern of risks, the toll due to heart disease could be much larger—and more immediate—than the burden of cancer and lung disease that has been used to develop current air pollution standards. It is time for organizations concerned with heart health, including the American College of Cardiology and the American Heart Association, as well as traditional environmental organizations and environmental regulators, to consider seriously the cardiovascular effects of air pollution when developing and implementing standards to clear the air and protect public health. Reprint requests and correspondence: Dr. Stanton A. Glantz, Professor of Medicine, Box 0130, University of California, San Francisco, California 94143. E-mail: [email protected].
REFERENCES 1. Glantz SA. Heart disease and the environment. J Am Coll Cardiol 1993;21:1473–4. 2. Poloniecki JD, Atkinson RW, de Leon AP, Anderson HR. Daily time series for cardiovascular hospital admissions and previous day’s air pollution in London, UK. Occup Environ Med 1997;54:535–40. 3. Dockery DW, Pope CA, 3rd, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329: 1753–9.
JACC Vol. 39, No. 6, 2002 March 20, 2002:943–5 4. Pope CA, 3rd, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995;151 3:669 –74. 5. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987–1994. N Engl J Med 2000;343:1742–9. 6. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002;39:935– 42. 7. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–71. 8. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844 –50. 9. Peters A, Frohlich M, Doring A, et al. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J 2001;22:1198 –204. 10. Seaton A, Soutar A, Crawford V, et al. Particulate air pollution and the blood. Thorax 1999;54:1027–32. 11. Peters A, Doring A, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997;349:1582–7. 12. Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation 1991;83:1–12. 13. Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA 1995;273:1047–53. 14. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation 1993;88: 1820 –5. 15. Penn A, Chen LC, Snyder CA. Inhalation of steady-state sidestream smoke from one cigarette promotes atherosclerotic plaque development. Circulation 1994:1363–7. 16. Zhu B-Q, Sun Y-P, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 1994;889:1282–90. 17. Sun YP, Zhu BQ, Browne AE, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation 2001;104:810 –4. 18. Penn A, Batastini G, Soloman J, Burns F, Albert R. Dose-dependent size increases of aortic lesions following chronic exposure to 7,12dimethylbenz(a)anthracene. Cancer Res 1981;41:588 –92. 19. Penn A, Snyder C. 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates atherosclerotic plaque development. Circulation 1996;93:552–7. 20. Pope CA, 3rd, Verrier RL, Lovett EG, et al. Heart rate variability associated with particulate air pollution. Am Heart J 1999;138:890 –9. 21. Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart rate variability. Circulation 2000;101:1267–73. 22. Peters A, Perz S, Doring A, Stieber J, Koenig W, Wichmann HE. Increases in heart rate during an air pollution episode. Am J Epidemiol 1999;150:1094 –8. 23. Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health 2001;91:571–7. 24. Linn WS, Gong H, Jr. Air pollution, weather stress, and blood pressure. Am J Public Health 2001;91:1345–6. 25. Singh N, Mironov D, Armstrong PW, Ross AM, Langer A, GUSTO ECG Substudy/nvestigators. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. Global Utilization of Streptokinase and TPA for Occluded Arteries. Circulation 1996;93:1388 –95. 26. Kleiger RE, Miller JP, Bigger JT, Jr., Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256 –62. 27. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 2001; 104:986 –91. 28. Pope CA, 3rd, Eatough DJ, Gold DR, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect 2001;109:711–6. 29. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001;103:2810 –5.
JACC Vol. 39, No. 6, 2002 March 20, 2002:943–5 30. Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995;130:1270 –5. 31. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 2001;286:436 –41. 32. Celermajer D, Adams M, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med 1996;334:150 –4. 33. Glantz SA, Parmley WW. Even a little secondhand smoke is dangerous. JAMA 2001;286:462–3. 34. Sun Y, Zhu B, Sievers R, Glantz S, Deedwania P, Parmley W.
Glantz Editorial Comment
945
L-Arginine preserves endothelial-dependent relaxation during environmental tobacco smoke in lipid-fed rabbits (abstr). Circulation 1994;90 Suppl I:I459. 35. Eilstein D, Quenel P, Hedelin G, Kleinpeter J, Arveiler D, Schaffer P. [Air pollution and myocardial infarction. Strasbourg France, 1984 – 89]. Rev Epidemiol Sante Publique 2001;49:13–25. 36. National Cancer Institute. Health effects of exposure to environmental tobacco smoke: the report of the California Environmental Protectional Agency (Smoking and Health Monograph 10). Bethesda, MD: National Cancer Institute; 1999. Report No.: NIH Pub. No. 88 – 4645.